Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
US GAUCHER DISEASE Competitive Intelligence
US GAUCHER DISEASE Competitive Intelligence
Eliglustat is Gaucher's only first-line oral therapy, cutting spleen volume 30% versus placebo in ENGAGE, at an annual WAC of $310,250.
Gaucher disease type 1...
